Email page PDF view Print view Email Alert Social media sharing

Press Release

Stericycle, Inc. Reports Results for the Third Quarter and Year to Date 2016

Company Release - 10/27/2016 4:02 PM ET

LAKE FOREST, Ill., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the third quarter and year to date 2016.

THIRD QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:

  • Revenues of $890.1 million, up 23.9%, including a 2.5% negative impact from foreign exchange
  • GAAP gross profit of $379.3 million, up 26.6%
  • GAAP EPS decreased 11.1% to $0.72 and Non-GAAP EPS increased 7.8% to $1.24

THIRD QUARTER RESULTS

Revenues for the quarter ended September 30, 2016 were $890.1 million, up 23.9% from $718.6 million in the third quarter of last year. Acquisitions contributed approximately $184.7 million to the current period’s growth in revenues.  Revenues increased 26.4% compared to the third quarter of last year when adjusted for unfavorable foreign exchange impacts of $18.3 million. Organic revenues grew 0.7%, or 1.6% when adjusted for manufacturing and industrial services. See Tables 1A-1C.

Gross profit, reported in accordance with U.S. generally accepted accounting principles (“GAAP”), was $379.3 million, up 26.6% from $299.7 million in the third quarter of last year.  GAAP gross profit as a percentage of revenue was 42.6% compared to 41.7% in the third quarter of last year. Non-GAAP gross profit, when adjusted for contract exit costs and plant conversion expenses as identified in Table 2, was $381.0 million, an increase of 26.9% from $300.2 million in the third quarter of last year. Non-GAAP gross profit as a percentage of revenues was 42.8% compared to 41.8% in the third quarter of last year.

“We were able to maintain consistent margin performance in the quarter despite revenue headwinds from previously discussed pricing pressure and softness in the manufacturing and industrial market,” said Charlie Alutto, President and Chief Executive Officer.

GAAP earnings per diluted share decreased 11.1% to $0.72 from $0.81 in the third quarter of last year. Non-GAAP earnings per diluted share, when adjusted for various items, increased 7.8% to $1.24 from $1.15 in the third quarter of last year. See Tables 3 and 4.

“Our record free cash flow in the quarter allowed us to accelerate our capital allocation strategy, contributing to our EPS growth,” said Dan Ginnetti, Chief Financial Officer. “We were able to significantly reduce our debt by approximately $100 million, repurchase 265,000 of mandatory convertible preferred stock, and close five acquisitions.” 

NINE MONTHS HIGHLIGHTS COMPARED TO PRIOR YEAR:

  • Revenues of $2.66 billion, up 26.6%, including a 3.0% negative impact from foreign exchange
  • GAAP gross profit of $1.13 billion, up 27.5%
  • GAAP EPS decreased 10.6% to $1.93 and Non-GAAP EPS increased 1.7% to $3.53

FIRST NINE MONTHS RESULTS

Revenues for the nine months ended September 30, 2016 were $2.66 billion, up 26.6% from $2.10 billion in the same period last year. Acquisitions contributed approximately $565.1 million to the current year’s growth in revenues. Revenues increased 29.6% compared to the same period last year when adjusted for unfavorable foreign exchange impact of $62.1 million. Organic revenues grew 2.6%, or 3.9% when adjusted for manufacturing and industrial services. See Tables 1A-1C.

GAAP gross profit was $1.13 billion, up 27.5% from $885.8 million in the same period last year. GAAP gross profit as a percentage of revenues was 42.5% compared to 42.2% in the same period last year. Non-GAAP gross profit, when adjusted for contract exit costs and plant conversion expenses as identified in Table 2, was $1.13 billion, up 27.6% from $886.8 million in the same period as last year. Non-GAAP gross profit as a percentage of revenues was 42.6% compared to 42.3% in the same period last year.

GAAP earnings per diluted share decreased 10.6% to $1.93 from $2.16 in the same period last year. Non-GAAP earnings per diluted share, when adjusted for various items, increased 1.7% to $3.53 from $3.47 in the same period last year. See Tables 3 and 4.

Cash flow from operations for the nine months ended September 30, 2016 was $417.8 million, up 42.4% from $293.3 million in the same period last year.

CONFERENCE CALL INFORMATION

Conference call to be held October 27, 2016 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through November 27th by dialing 855-859-2056, access code 21518012. To hear a live simulcast of the call or access the audio archive, visit the investor relations page on www.stericycle.com.

PRESENTATION OF NON-GAAP INFORMATION

This press release includes certain non-GAAP financial measures, as defined in the SEC’s Regulation G. The Company reports its financial results in compliance with GAAP, but believes that also discussing non-GAAP financial measures allows for a better period over period comparison by removing the impact of items that, in management’s view, do not reflect the Company’s underlying operating performance. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation.

Adjusted diluted earnings per share, adjusted net income, adjusted gross profit, and adjusted sales growth are described in the Reconciliation of Certain Non-GAAP Measures section of this document.

These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results, but should be read in conjunction with the unaudited condensed consolidated statement of income and other information presented herein. The non-GAAP financial measures in the press release may differ from similar measures used by other companies. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP measure is included in the accompanying tables.

DISCUSSION OF ADJUSTING ITEMS FOR NON-GAAP MEASURES

For the purpose of evaluating revenues, we present non-GAAP revenues to show the impact of foreign currency, revenues from acquisitions and Manufacturing and Industrial Services (“M&I”). Management reviews and analyzes revenues excluding the effect of foreign currency translation and revenue from acquisitions because we believe this better represents the Company’s underlying business trends, including organic revenue growth. Separate presentation of M&I allows for visibility of a revenue stream that has shown greater volatility than our other service lines.

For the purpose of evaluating operating performance, we present our financials to show the impact of income and expenses in our non-GAAP earnings related to acquisitions. These adjustments include acquisition expense, integration expense, amortization expense, and the change in fair value of contingent consideration. This allows for comparison of period over period results without the impact of acquisition-related expenses.

For the purpose of evaluating operating performance, we additionally present our financials to show the impact of certain expenses and income in our non-GAAP earnings to allow for period over period comparison of financials without the impact of charges that may not occur each year and if so, are due to different factors. For the periods presented, these adjustments include litigation expense, restructuring and plant conversion expenses, contract exit costs, and insurance proceeds.

For the purpose of calculating the ultimate impact of our mandatory convertible preferred stock, we show the impact to our EPS by excluding the mandatory convertible preferred stock dividend and using the “if-converted” method of share dilution. This provides the reader insight to how our diluted shares will be affected after these preferred shares are converted to common shares.

RECONCILIATION OF CERTAIN NON-GAAP MEASURES

Table 1 – A: RECONCILIATION OF GAAP TO NON-GAAP REVENUE GROWTH – QTD Q3

 Three Months Ended September 30, 2016 and 2015 
 In millions  Percentage Growth (%) 
Global Revenue Details by Service 2016    2015  Growth  Organic Acquisitions Foreign
Exchange
 Total 
Regulated Waste and Compliance Services$520.4    $521.0  $(0.6)  1.7% 0.4% (2.2%) (0.1%)
Secure Information Destruction Services 187.1     -   187.1  N/A N/A N/A N/A 
Communication and Related Services 87.5     93.2   (5.7)  (5.5%) 0.8% (1.4%) (6.1%)
Manufacturing and Industrial Services 95.2     104.5   (9.3)  (4.4%) 0.8% (5.2%) (8.9%)
Total Revenues, as Reported 890.1     718.6   171.5   0.7% 25.7% (2.5%) 23.9%
Less: Manufacturing and Industrial Services (95.2)    (104.5)                 
Total Revenues, as Adjusted (Non-GAAP)$795.0    $614.1  $180.8   1.6% 29.9% (2.1%) 29.4%
                           
Domestic Revenues$664.1    $523.5  $140.6   (0.1%) 27.0%   26.9%
International Revenues 226.1     195.1   31.0   3.0% 22.3% (9.4%) 15.9%
Total Revenues, as Reported$890.1    $718.6  $171.5   0.7% 25.7% (2.5%) 23.9%
                           

Table 1 – B: RECONCILIATION OF GAAP TO NON-GAAP REVENUE GROWTH – YTD Q3

 Nine Months Ended September 30, 2016 and 2015 
 In millions  Percentage Growth (%) 
Global Revenue Details by Service2016    2015  Growth  Organic Acquisitions Foreign
Exchange
 Total 
Regulated Waste and Compliance Services$1,550.3    $1,544.6  $5.7   2.5% 0.6% (2.7%) 0.4%
Secure Information Destruction Services 562.3     -   562.3  N/A N/A N/A N/A 
Communication and Related Services 258.0     247.6   10.4   3.2% 2.4% (1.4%) 4.2%
Manufacturing and Industrial Services 285.4     305.4   (20.0)  (4.5%) 3.4% (5.5%) (6.5%)
Total Revenues, as Reported 2,655.9     2,097.6   558.3   2.6% 26.9% (3.0%) 26.6%
Less: Manufacturing and Industrial Services (285.4)    (305.4)                 
Total Revenues, as Adjusted (Non-GAAP)$2,370.5    $1,792.2  $578.3   3.9% 30.9% (2.5%) 32.3%
                           
Domestic Revenues$1,970.9    $1,513.9  $456.9   1.8% 28.4%   30.2%
International Revenues 685.1     583.7   101.4   5.0% 23.0% (10.6%) 17.4%
Total Revenues, as Reported$2,655.9    $2,097.6  $558.3   2.6% 26.9% (3.0%) 26.6%
                           

Table 1 – C: DISAGGREGATED REVENUE GROWTH – 2016

In millions 
 Three Months Ended
September 30, 2016
    Nine Months Ended
September 30, 2016
 
Organic$5.1    $55.3 
Acquisitions 184.7     565.1 
Foreign Exchange (18.3)    (62.1)
Total Growth$171.5    $558.3 
          

Table 2: RECONCILIATION OF GAAP TO NON-GAAP GROSS PROFIT

In millions                           
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2016  2015  2016  2015 
 $ % of Rev  $ % of Rev  $ % of Rev  $ % of Rev 
Gross Profit, as Reported$379.3  42.6% $299.7  41.7% $1,129.5  42.5% $885.8  42.2%
Contract exit costs 1.7  0.2%  -  0.0%  1.7  0.1%  -  0.0%
Plant Conversion Expenses (0.0) 0.0%  0.5  0.1%  0.8  0.0%  1.0  0.0%
Gross Profit, as Adjusted (Non-GAAP)$381.0  42.8% $300.2  41.8% $1,132.0  42.6% $886.8  42.3%
                            

Table 3: RECONCILIATION OF GAAP TO NON-GAAP NET INCOME ATTRIBUTABLE TO STERICYCLE COMMON SHAREHOLDERS

In millions, except share and per share data 
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2016 2015  2016 2015 
Net Income Attributable to Stericycle, Inc. Common Shareholders, As Reported$61.5 $69.4  $165.5 $186.2 
Adjustments:             
Acquisition Expenses 2.3  33.7   7.9  39.9 
Integration Expenses 19.2  13.4   61.0  31.2 
Litigation Expenses 1.5  (16.4)  5.4  59.0 
Changes in Fair Value of Contingent Consideration 0.6  -   (2.1) (0.6)
Restructuring and Plant Conversion Expenses 0.5  2.7   1.7  18.1 
Contract Exit Costs 10.1  -   22.8  - 
Insurance Proceeds (3.1) -   (3.1) - 
Amortization Expense a 33.1  9.2   102.3  27.0 
Add Back Convertible Preferred Stock Dividend 9.7  -   29.9  - 
Total Adjustments 73.9  42.6   225.8  174.6 
Tax Effect of above adjustments b (22.6) (12.2)  (69.4) (60.3)
Net Income Attributable to Stericycle, Inc. Common Shareholders, as Adjusted (Non-GAAP)$112.8 $99.8  $321.9 $300.5 
EPS, as Reported$0.72 $0.81  $1.93 $2.16 
EPS, as Adjusted (Non-GAAP)$1.24 $1.15  $3.53 $3.47 
Weighted average number of common shares outstanding - diluted 85,570,529  86,120,315   85,689,525  86,234,859 
Additional Dilution Under If-Converted Method 5,495,861  -   5,590,105  - 
Diluted Weighted Average Number of Common Shares Outstanding Under If-Converted Method 91,066,390  86,120,315   91,279,630  86,234,859 


a) Beginning in the quarter ended March 31, 2016, the Company has started to exclude amortization expense from non-GAAP EPS. For comparable reporting, the Company’s previously reported 2015 results are adjusted to reflect the change.
b) The tax effect of the adjustments is calculated based on applying the appropriate tax rate for the jurisdictions in which the adjustment occurred for the respective periods.
 

Table 4: RECONCILIATION OF GAAP TO NON-GAAP EPS

 Three Months Ended September 30,  Nine Months Ended September 30, 
         Change          Change 
 2016  2015  $ %  2016  2015  $ % 
EPS, as Reported$0.72  $0.81  $(0.09) -11.1% $1.93  $2.16  $(0.23) -10.6%
Acquisition Expenses 0.02   0.27          0.06   0.33        
Integration Expenses 0.14   0.10          0.45   0.23        
Litigation Expenses 0.01   (0.12)         0.04   0.41        
Changes in Fair Value of Contingent Consideration 0.01   0.00          (0.02)  (0.01)       
Restructuring and Plant Conversion Expenses 0.00   0.02          0.01   0.14        
Contract Exit Costs 0.10   0.00          0.20   0.00        
Insurance Proceeds (0.04)  0.00          (0.03)  0.00        
Amortization Expense 0.25   0.07          0.77   0.21        
Add Back Convertible Preferred Stock Dividend 0.11   0.00          0.35   0.00        
Total Impact of All Adjustments Including Convertible Preferred Stock Dividend (0.08)  0.00          (0.23)  0.00        
EPS, as Adjusted (Non-GAAP)$1.24  $1.15  $0.09  7.8% $3.53  $3.47  $0.06  1.7%
Diluted Weighted Average Number of Common Shares Outstanding Under If-Converted Method 91,066,390   86,120,315          91,279,630   86,234,859        
                              

For more information about Stericycle, please visit our website at www.stericycle.com

Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic and market conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of the collection, transportation, treatment and disposal of regulated waste or the proper handling and protection of personal and confidential information, increases in transportation and other operating costs, the level of governmental enforcement of regulations governing regulated waste collection and treatment or the proper handling and protection of personal and confidential information, our obligations to service our substantial indebtedness and to comply with the covenants and restrictions contained in our private placement notes, term loan credit facility and revolving credit facility, our ability to execute our acquisition strategy and to integrate acquired businesses, competition and demand for services in the regulated waste and secure information destruction industries, political, economic and currency risks related to our foreign operations, impairments of goodwill or other indefinite-lived intangibles, variability in the demand for services we provide on a project or non-recurring basis, exposure to environmental liabilities, fluctuations in the price we receive for the sale of paper, disruptions in or attacks on our information technology systems, compliance with existing and future legal and regulatory requirements, as well as other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.

STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 
(IN THOUSANDS) 
        
 September 30,  December 31, 
 2016  2015 
ASSETS       
Current Assets:       
Cash and cash equivalents$40,291  $55,634 
Short-term investments 63   69 
Accounts receivable, net 637,921   614,494 
Prepaid expenses 52,134   46,740 
Other current assets 43,529   44,891 
Total Current Assets 773,938   761,828 
Property, plant and equipment, net 738,106   665,602 
Goodwill 3,597,034   3,758,177 
Intangible assets, net 1,926,974   1,842,561 
Other assets 31,544   36,995 
Total Assets$7,067,596  $7,065,163 
        
LIABILITIES AND EQUITY       
Current Liabilities:       
Current portion of long-term debt$91,008  $161,409 
Accounts payable 146,400   149,202 
Accrued liabilities 211,762   197,329 
Deferred revenues 15,536   16,989 
Other current liabilities 73,021   62,420 
Total Current Liabilities 537,727   587,349 
        
Long-term debt, net of current portion 2,921,770   3,040,352 
Deferred income taxes 654,495   608,272 
Other liabilities 84,483   81,352 
Equity:       
Mandatory convertible preferred stock 7   8 
Common stock 851   849 
Additional paid-in capital 1,167,756   1,143,020 
Accumulated other comprehensive loss (304,168)  (282,631)
Retained earnings 1,993,343   1,868,645 
Total Stericycle, Inc. Equity 2,857,789   2,729,891 
Noncontrolling interests 11,332   17,947 
Total Equity 2,869,121   2,747,838 
Total Liabilities and Equity$7,067,596  $7,065,163 


STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME 
(IN THOUSANDS, EXCEPT SHARES AND PER SHARE DATA) 
                            
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2016  2015  2016  2015 
 $ % of Rev  $ % of Rev  $ % of Rev  $ % of Rev 
                            
Revenues$890,144  100.0% $718,596  100.0% $2,655,946  100.0% $2,097,604  100.0%
Cost of revenues ("COR") exclusive of depreciation 488,154  54.8%  404,918  56.3%  1,457,425  54.9%  1,169,051  55.7%
Depreciation 22,730  2.6%  14,003  1.9%  68,982  2.6%  42,723  2.0%
Total cost of revenues 510,884  57.4%  418,921  58.3%  1,526,407  57.5%  1,211,774  57.8%
                            
Gross profit, as reported 379,260  42.6%  299,675  41.7%  1,129,539  42.5%  885,830  42.2%
Gross profit, as adjusted (non-GAAP) 380,982  42.8%  300,162  41.8%  1,132,014  42.6%  886,831  42.3%
                            
Selling, general and administrative expenses ("SG&A") exclusive of depreciation 245,245  27.6%  166,671  23.2%  739,294  27.8%  536,004  25.6%
Depreciation 9,498  1.1%  4,248  0.6%  25,097  0.9%  12,753  0.6%
Total SG&A expense, as reported 254,743  28.6%  170,919  23.8%  764,391  28.8%  548,757  26.2%
Total SG&A expense, as adjusted (non-GAAP) 189,269  21.3%  128,769  17.9%  567,846  21.4%  375,141  17.9%
                            
Income from operations, as reported 124,517  14.0%  128,756  17.9%  365,148  13.7%  337,073  16.1%
Income from operations, as adjusted (non-GAAP) exclusive of adjusting items shown below 191,713  21.5%  171,393  23.9%  564,168  21.2%  511,690  24.4%
                            
Adjusting items:                           
Contract exit costs (COR) 1,715  0.2%  -  0.0%  1,715  0.1%  -  0.0%
Plant conversion expenses (COR) 7  0.0%  487  0.1%  760  0.0%  1,001  0.0%
Acquisition expenses (SG&A) 2,265  0.3%  33,674  4.7%  7,862  0.3%  39,956  1.9%
Integration expenses (SG&A) 19,162  2.2%  13,447  1.9%  61,008  2.3%  31,257  1.5%
Litigation expenses (SG&A) 1,481  0.2%  (16,444) -2.3%  5,445  0.2%  59,006  2.8%
Change in fair value of contingent consideration (SG&A) 559  0.1%  -  0.0%  (2,085) -0.1%  (640) 0.0%
Restructuring and plant conversion expenses (SG&A) 484  0.1%  2,234  0.3%  901  0.0%  17,080  0.8%
Contract exit costs (SG&A) 8,395  0.9%  -  0.0%  21,103  0.8%  -  0.0%
Amortization (SG&A) 33,128  3.7%  9,239  1.3%  102,311  3.9%  26,957  1.3%
Total adjustments 67,196  7.5%  42,637  5.9%  199,020  7.5%  174,617  8.3%
                            
Other income (expense):                           
Interest expense, net (24,690) -2.8%  (17,378) -2.4%  (73,089) -2.8%  (52,366) -2.5%
Other income/ (expense), net 2,932  0.3%  (1,754) -0.2%  (437) 0.0%  (3,956) -0.2%
Total other expense (21,758) -2.4%  (19,132) -2.7%  (73,526) -2.8%  (56,322) -2.7%
                            
Income before income taxes 102,759  11.5%  109,624  15.3%  291,622  11.0%  280,751  13.4%
                            
Income tax expense 37,586  4.2%  39,718  5.5%  102,624  3.9%  93,276  4.4%
                            
Net income 65,173  7.3%  69,906  9.7%  188,998  7.1%  187,475  8.9%
                            
Less: net income attributable to noncontrolling interests 378  0.0%  457  0.1%  1,383  0.1%  1,256  0.1%
                            
Net income attributable to Stericycle, Inc. 64,795  7.3%  69,449  9.7%  187,615  7.1%  186,219  8.9%
                            
Less: mandatory convertible preferred stock dividend 9,726  1.1%  -  0.0%  29,853  1.1%  -  0.0%
Less: gain on repurchase of preferred stock (6,467) -0.7%  -  0.0%  (7,747) -0.3%  -  0.0%
                            
Net income attributable to Stericycle, Inc. common shareholders$61,536  6.9% $69,449  9.7% $165,509  6.2% $186,219  8.9%
                            
Earnings per share - diluted$0.72     $0.81     $1.93     $2.16    
                            
Weighted average number of common shares outstanding - diluted 85,570,529      86,120,315      85,689,525      86,234,859    


STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(IN THOUSANDS) 
 Nine Months Ended September 30, 
 2016  2015 
Operating Activities:       
Net income$188,998  $187,475 
Adjustments to reconcile net income to net cash provided by operating activities:       
Stock compensation expense 16,671   16,158 
Excess tax benefit of stock options exercised -   (15,483)
Depreciation 94,079   55,476 
Amortization 102,311   26,957 
Deferred income taxes 20,579   (15,218)
Other, net (2,296)  5,686 
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:       
Accounts receivable (26,825)  (66,352)
Accounts payable 681   29,170 
Accrued liabilities 6,141   77,820 
Deferred revenue (1,230)  (3,412)
Other assets and liabilities 18,659   (4,986)
Net cash provided by operating activities 417,768   293,291 
        
Investing Activities:       
Payments for acquisitions, net of cash acquired (51,197)  (97,098)
Proceeds from investments 7   (635,919)
Proceeds from insurance settlement 2,358   - 
Proceeds from sale of property and equipment 1,316   - 
Capital expenditures (100,981)  (72,566)
Net cash used in investing activities (148,497)  (805,583)
        
Financing Activities:       
Repayments of long-term debt and other obligations (52,462)  (61,805)
Proceeds from foreign bank debt 68,711   42,535 
Repayments of foreign bank debt (68,211)  (76,387)
Proceeds from term loan -   250,000 
Repayments of term loan (250,000)  (250,000)
Proceeds from private placement of pf long-term note     300,000 
Repayments of private placement pf long-term note     (100,000)
Proceeds from senior credit facility 1,205,270   1,338,140 
Repayments of senior credit facility (1,118,831)  (1,614,968)
Repayments of capital lease obligations (4,644)  (2,813)
Payments of deferred financing costs (605)  - 
Payment for hedge -   (8,833)
Payments for repurchase of common stock (40,814)  (103,029)
Payments for repurchase of convertible preferred stock (24,263)  - 
Proceeds from issuances of mandatory convertible preferred stock -   746,900 
Proceeds from issuances of common stock 35,727   53,529 
Dividends paid on mandatory convertible preferred stock (29,853)  - 
Excess tax benefit of stock options exercised -   15,483 
Payments to noncontrolling interests (6,961)  (5,236)
Net cash (used in)/ provided by financing activities (286,936)  523,516 
Effect of exchange rate changes on cash and cash equivalents 2,322   (577)
Net (decrease)/ increase in cash and cash equivalents (15,343)  10,647 
Cash and cash equivalents at beginning of period 55,634   22,236 
        
Cash and cash equivalents at end of period$40,291  $32,883 
        
Non-cash activities:       
Net issuances of obligations for acquisitions$31,394  $71,905 

 

FOR FURTHER INFORMATION CONTACT:

Investor Relations 847-607-2012

Primary Logo

Source: Stericycle, Inc.